According to Nectar Lifesciences 's latest financial reports and stock price the company's current Operating Margin is 2.63%. At the end of 2022 the company had an Operating Margin of 2.04%.
Year | Operating Margin | Change |
---|---|---|
2022 | 2.04% | -137.18% |
2021 | -5.49% | -446.87% |
2020 | 1.58% | -25.08% |
2019 | 2.11% | -36.73% |
2018 | 3.34% | -18.55% |
2017 | 4.10% | -5.19% |
2016 | 4.33% | -16.14% |
2015 | 5.16% | 8% |
2014 | 4.78% | -32.37% |
2013 | 7.06% | 7.74% |
2012 | 6.56% | -42.55% |
2011 | 11.41% | -12.33% |
2010 | 13.02% | 58.23% |
2009 | 8.23% | -23.01% |
2008 | 10.68% | -5.68% |
2007 | 11.33% | -27.92% |
2006 | 15.72% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.